{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:43:22Z","timestamp":1789055002819,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejps.2017.05.012","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T18:16:56Z","timestamp":1494526616000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Glucosamine modulates propranolol pharmacokinetics via intestinal permeability in rats"],"prefix":"10.1016","volume":"105","author":[{"given":"Hanadi A.","family":"Al Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidal A.","family":"Qinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujtaba","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.H.","family":"Al Omari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Idkaidek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Z.","family":"Matalka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan A.","family":"Badwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejps.2017.05.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1556\/1326.2017.00018","article-title":"RP-HPLC-UV method for the quantifcation of propranolol in rats's serum and Krebs buffer using one-step protein precipitation","author":"Al Shaker","year":"2017","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.ejps.2017.05.012_bb0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.colsurfb.2010.06.028","article-title":"Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding","volume":"81","author":"Al-Hamidi","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2017.05.012_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.fct.2004.11.006","article-title":"Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy","volume":"43","author":"Anderson","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejps.2017.05.012_bb0020","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1023\/A:1015831517800","article-title":"Sustained propranolol delivery and increased oral bioavailability in dogs given a propranolol laurate salt","volume":"9","author":"Aungst","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.05.012_bb0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11095-007-9523-x","article-title":"The use of BDDCS in classifying the permeability of marketed drugs","volume":"25","author":"Benet","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.05.012_bb0030","series-title":"Goodman and Gilman's, the Pharmacological Basis of Therapeutics","author":"Brunton","year":"2006"},{"key":"10.1016\/j.ejps.2017.05.012_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2125.1979.tb00896.x","article-title":"The effect of ageing on the hepatic clearance of propranolol","volume":"7","author":"Castleden","year":"1979","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.05.012_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000006955","article-title":"Beta-blockers after myocardial infarction: do benefits ever outweigh risks in asthma?","volume":"92","author":"Chafin","year":"1999","journal-title":"Cardiology"},{"key":"10.1016\/j.ejps.2017.05.012_bb0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jep.2005.08.020","article-title":"The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model","volume":"103","author":"Chan","year":"2006","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2017.05.012_bb0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/bdd.2510070605","article-title":"Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man","volume":"7","author":"Cid","year":"1986","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2017.05.012_bb0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.addr.2007.08.043","article-title":"Predicting drug disposition, absorption\/elimination\/transporter interplay and the role of food on drug absorption","volume":"60","author":"Custodio","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2017.05.012_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.bjp.0703518","article-title":"The organic cation transporter OCT2 mediates the uptake of \u03b2-adrenoceptor antagonists across the apical membrane of renal LLC-PK1 cell monolayers","volume":"131","author":"Dudley","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.05.012_bb0065","series-title":"European Medicines Agency (EMA)","article-title":"Guidlines on bioanalytical method validation","author":"EMEA","year":"2012"},{"key":"10.1016\/j.ejps.2017.05.012_bb0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2125.1983.tb02218.x","article-title":"Induction of propranolol metabolism by rifampicin","volume":"16","author":"Herman","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.05.012_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003088-199121010-00002","article-title":"Pharmacokinetics of rectal drug administration, part I","volume":"21","author":"van Hoogdalem","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.05.012_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/17425255.3.4.469","article-title":"Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans","volume":"3","author":"Hurst","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2017.05.012_bb0085","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1002\/jps.23145","article-title":"Absorption and bioavailability of glucosamine in the rat","volume":"101","author":"Ibrahim","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.05.012_bb0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.29333\/ejgm\/82227","article-title":"Bioequivalence study of propranolol tablets","volume":"1","author":"Ismail","year":"2004","journal-title":"Eur. J. Gen. Med."},{"key":"10.1016\/j.ejps.2017.05.012_bb0095","series-title":"Basic & Clinical Pharmacology","author":"Katzung","year":"2004"},{"key":"10.1016\/j.ejps.2017.05.012_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2007.07.019","article-title":"Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans","volume":"349","author":"Kiriyama","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.05.012_bb0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/230949900901700116","article-title":"Review article: Glucosamine","volume":"17","author":"Kirkham","year":"2009","journal-title":"J. Orthop. Surg. (Hong Kong)"},{"key":"10.1016\/j.ejps.2017.05.012_bb0110","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1002\/jps.23535","article-title":"Propranolol transport across the inner blood\u2013retinal barrier: potential involvement of a novel organic cation transporter","volume":"102","author":"Kubo","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.05.012_bb0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2125.1980.tb04793.x","article-title":"Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol","volume":"9","author":"Leahey","year":"1980","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.05.012_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0536.1995.tb00438.x","article-title":"The sodium lauryl sulfate model: an overview","volume":"33","author":"Lee","year":"1995","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ejps.2017.05.012_bb0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2010.10.017","article-title":"Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion","volume":"403","author":"Li","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.05.012_bb0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF02336686","article-title":"Mechanisms and variations in the food effect on propranolol bioavailability","volume":"38","author":"Liedholm","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.05.012_bb0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199120060-00001","article-title":"Nonlinear pharmacokinetics","volume":"20","author":"Ludden","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.05.012_bb0140","first-page":"7","article-title":"Beta-blockers in cardiovascular medicine","volume":"57","author":"Mansoor","year":"2009","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.ejps.2017.05.012_bb0145","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1940-6207.CAPR-11-0450","article-title":"Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis","volume":"5","author":"Nkontchou","year":"2012","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ejps.2017.05.012_bb0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3565(24)35123-7","article-title":"Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs","volume":"291","author":"Palm","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.05.012_bb0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jps.24269","article-title":"Glucosamine enhances paracetamol bioavailability by reducing its metabolism","volume":"104","author":"Qinna","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.05.012_bb0160","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2125.1981.tb01307.x","article-title":"Cimetidine increases steady state plasma levels of propranolol","volume":"12","author":"Reimann","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.05.012_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pcad.2004.04.004","article-title":"Cardiovascular drug class specificity: \u03b2-blockers","volume":"47","author":"Reiter","year":"2004","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.ejps.2017.05.012_bb0170","doi-asserted-by":"crossref","first-page":"41527","DOI":"10.1074\/jbc.R100053200","article-title":"Reflections on glycobiology","volume":"276","author":"Roseman","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2017.05.012_bb0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0168-3659(98)00189-8","article-title":"Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum","volume":"59","author":"Ryu","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2017.05.012_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1056-8719(97)00100-7","article-title":"Development of an optimal method for the dual perfusion of the isolated rat liver","volume":"39","author":"Sahin","year":"1998","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejps.2017.05.012_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/15376511003602112","article-title":"Quantitative determination of propranolol by ultraviolet HPLC in human plasma","volume":"20","author":"Salman","year":"2010","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.ejps.2017.05.012_bb0190","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3109\/03639049309063003","article-title":"Formulation, phafmacokinetic and pharmacodynamic evaluation of fast releasing compressed propranolol. HCL suppositories","volume":"19","author":"Sastry","year":"1993","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2017.05.012_bb0195","article-title":"Isolation and primary culture of rat hepatic cells","volume":"64","author":"Shen","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejps.2017.05.012_bb0200","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/brain\/awh298","article-title":"Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?","volume":"128","author":"Shields","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ejps.2017.05.012_bb0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0003-4975(10)61647-5","article-title":"Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study","volume":"29","author":"Stephenson","year":"1980","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ejps.2017.05.012_bb0210","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1124\/jpet.103.054320","article-title":"Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice","volume":"307","author":"Tallarida","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.05.012_bb0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(02)03058-2","article-title":"GLUT2 is a high affinity glucosamine transporter","volume":"524","author":"Uldry","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2017.05.012_bb0220","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/js970218s","article-title":"Membrane transport of drugs in different regions of the intestinal tract of the rat","volume":"87","author":"Ungell","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.05.012_bb0225","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1208\/s12248-013-9479-1","article-title":"Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol)-application of a new \"physiologically based\" model to assess absorption and disposition","volume":"15","author":"Wang","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2017.05.012_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.05.012_bb0235","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.bmc.2005.10.018","article-title":"The antioxidant activity of glucosamine hydrochloride in vitro","volume":"14","author":"Xing","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2017.05.012_bb0240","first-page":"2516","article-title":"pH dependent but not P-gp dependent bidirectional transport study of S-propranolol: the importance of passive diffusion","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717302403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717302403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T13:04:11Z","timestamp":1750251851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717302403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":48,"alternative-id":["S0928098717302403"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.05.012","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucosamine modulates propranolol pharmacokinetics via intestinal permeability in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}